Arkolith/Insider Trading/INMB/Form 4

Ellspermann Cory Randall

Interim CFOInmune Bio, Inc. (INMB) · full profile →Form 4 · filed Nov 18, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 18, 2025Grant(A)75K——75K
Nov 18, 2025Disposed to issuer(D)75K——0
Nov 18, 2025Grant(A)30K——30K
Nov 18, 2025Disposed to issuer(D)40K——0
Nov 18, 2025Disposed to issuer(D)30K——0
Nov 18, 2025Grant(A)40K——40K
Nov 18, 2025Disposed to issuer(D)30K——0
Nov 18, 2025Grant(A)30K——30K
Nov 18, 2025Disposed to issuer(D)70K——0
Nov 18, 2025Grant(A)70K——70K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-112227) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML